Healthcare provider profile · identity verified

Mark Willis Corry, MD

Family Practice · CEDAR CITY, UT · NPI 1033347158

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	413	125
Omeprazole	Omeprazole	372	108
Atorvastatin Calcium	Atorvastatin Calcium	370	107
Losartan Potassium	Losartan Potassium	307	98
Amlodipine Besylate	Amlodipine Besylate	279	82
Lisinopril	Lisinopril	275	81
Rosuvastatin Calcium	Rosuvastatin Calcium	223	71
Gabapentin	Gabapentin	219	70
Tamsulosin Hcl	Tamsulosin Hcl	215	71
Metformin Hcl	Metformin Hcl	205	70
Zolpidem Tartrate	Zolpidem Tartrate	200	37
Pantoprazole Sodium	Pantoprazole Sodium	196	59
Trazodone Hcl	Trazodone Hcl	172	50
Alprazolam	Alprazolam	161	25
Metoprolol Succinate	Metoprolol Succinate	156	45
Potassium Chloride	Potassium Chloride	148	42
Clonazepam	Clonazepam	130	26
Sertraline Hcl	Sertraline Hcl	128	37
Allopurinol	Allopurinol	125	36
Fluoxetine Hcl	Fluoxetine Hcl	125	37
Eliquis	Apixaban	121	24
Montelukast Sodium	Montelukast Sodium	121	31
Furosemide	Furosemide	120	30
Hydrochlorothiazide	Hydrochlorothiazide	118	35
Tramadol Hcl	Tramadol Hcl	107	20
Amoxicillin	Amoxicillin	106	80
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	103	49
Albuterol Sulfate Hfa	Albuterol Sulfate	102	46
Temazepam	Temazepam	96	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	95	17
Simvastatin	Simvastatin	94	32
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	93	28
Metoprolol Tartrate	Metoprolol Tartrate	92	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	90	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	84	35
Meloxicam	Meloxicam	83	25
Duloxetine Hcl	Duloxetine Hcl	80	22
Celecoxib	Celecoxib	79	30
Fluticasone Propionate	Fluticasone Propionate	79	25
Pravastatin Sodium	Pravastatin Sodium	77	23
Bupropion Xl	Bupropion Hcl	75	17
Venlafaxine Hcl Er	Venlafaxine Hcl	71	13
Finasteride	Finasteride	68	24
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	68	39
Prednisone	Prednisone	66	45
Hydroxyzine Pamoate	Hydroxyzine Pamoate	64	13
Quetiapine Fumarate	Quetiapine Fumarate	62	suppressed
Mounjaro	Tirzepatide	60	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	57	17
Eszopiclone	Eszopiclone	56	17
Clopidogrel	Clopidogrel Bisulfate	54	17
Famotidine	Famotidine	54	15
Glipizide	Glipizide	52	20
Bupropion Hcl Sr	Bupropion Hcl	51	11
Pregabalin	Pregabalin	51	12
Buspirone Hcl	Buspirone Hcl	50	15
Estradiol	Estradiol	50	22
Ondansetron Hcl	Ondansetron Hcl	50	22
Oxybutynin Chloride	Oxybutynin Chloride	49	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	46	29
Linzess	Linaclotide	46	suppressed
Cephalexin	Cephalexin	44	27
Citalopram Hbr	Citalopram Hydrobromide	44	suppressed
Atenolol	Atenolol	42	13
Triamcinolone Acetonide	Triamcinolone Acetonide	42	22
Mirtazapine	Mirtazapine	41	suppressed
Olanzapine	Olanzapine	40	suppressed
Spironolactone	Spironolactone	40	14
Trulicity	Dulaglutide	40	13
Acetaminophen-Codeine	Acetaminophen With Codeine	39	suppressed
Baclofen	Baclofen	39	suppressed
Metformin Hcl Er	Metformin Hcl	39	14
Arnuity Ellipta	Fluticasone Furoate	38	suppressed
Meclizine Hcl	Meclizine Hcl	38	15
Propranolol Hcl	Propranolol Hcl	38	12
Xarelto	Rivaroxaban	38	suppressed
Ibuprofen	Ibuprofen	37	17
Bupropion Hcl	Bupropion Hcl	36	12
Valacyclovir	Valacyclovir Hcl	36	22
Carvedilol	Carvedilol	35	12
Doxycycline Monohydrate	Doxycycline Monohydrate	35	28
Sucralfate	Sucralfate	35	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	31
Divalproex Sodium	Divalproex Sodium	34	suppressed
Lovastatin	Lovastatin	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	11
Rizatriptan	Rizatriptan Benzoate	33	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	32	suppressed
Nystatin	Nystatin	31	19
Lorazepam	Lorazepam	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Azithromycin	Azithromycin	23	17
Fenofibrate	Fenofibrate,micronized	23	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Naproxen	Naproxen	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Diazepam	Diazepam	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Primidone	Primidone	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Fluconazole	Fluconazole	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Glimepiride	Glimepiride	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Phenobarbital	Phenobarbital	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Valproic Acid	Valproic Acid	15	suppressed
Betamethasone Valerate	Betamethasone Valerate	14	suppressed
Torsemide	Torsemide	14	suppressed
Irbesartan	Irbesartan	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Viberzi	Eluxadoline	13	suppressed
Calcitriol	Calcitriol	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Pen Needles	Pen Needle, Diabetic	12	suppressed
Ramipril	Ramipril	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	11	suppressed
Novolin R Flexpen	Insulin Regular, Human	11	suppressed
Olanzapine Odt	Olanzapine	11	suppressed
Ozempic	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error